United Kingdom Peptide Synthesis Market Size, Share, By Technology (Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), and Hybrid Technology), By Application (Therapeutics, Cancer, Metabolic, Cardiovascular Disorder, Infectious Diseases, CNS, Gastrointestinal Disorders (GIT), Pain, Respiratory, Dermatology, Renal Disorders, and Others), End Use (Pharmaceutical & Biotechnology Companies, CDMOs & CROs, and Academic & Research Institutes), United Kingdom Peptide Synthesis Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Peptide Synthesis Market Insights Forecasts to 2035

• United Kingdom Peptide Synthesis Market Size 2024: USD 47.3 Million
• United Kingdom Peptide Synthesis Market Size 2035:  USD 138.6 Million
• United Kingdom Peptide Synthesis Market CAGR 2024: 10.27%
• United Kingdom Peptide Synthesis Market Segments: Technology, Application, and End Use

In the UK, the peptide synthesis market is mature but growing steadily due to demand for therapeutic peptides, biologics, & personalized medicines. the market benefits from strong research & development investment, the rapid growth of pharmaceutical and biotechnology (pharma/biotech) drugs coming into development, and an increase in contract research organizations (CROS) and contract manufacturing organizations (CMOS) that provide tailored peptide service. Also driving the growth of the peptide synthesis market are various innovations or activities being developed by the government, coupled with strict regulatory guidelines and new solid phase and flow chemical technology development methods used for the development of peptides. Additionally, the automation of the production of peptides, AI-assisted design of the automated method of producing peptides, and the use of eco-friendly & sustainable green chemistry processes and chemicals are increasing the productivity of the peptide synthesis market.

The rising adoption of digital and automated manufacturing technologies by pharmaceutical or biotechnology companies is having a growing effect on the peptide synthesis market in the UK. Companies are utilizing automation/AI/digital quality management to speed both their research and production processes with automated solid-phase synthesizers, flow-based synthesis systems, AI-assisted design tools and digital quality management systems. The use of real-time reaction monitoring, machine learning-based sequence optimization, cloud-based lab management systems and advanced analytical tools such as LC-MS and HPLC will allow for improvement in efficiency, regulatory compliance and consistency of products.

Market Dynamics of the United Kingdom Peptide Synthesis Market

The UK market for peptide synthesis is driven by an increase in developing and producing medicinal peptides, the rising numbers of chronic diseases like autoimmune disorder, chronic-multicombined, metabolic and other diseases and growing demands for medicines created using targeted drugs or the precision medicines. The increasing applications for use of peptides in four of the major fields like oncology and endocrinology, infectious diseases, and the metabolic disorders, as well as the increasing number of pharmaceutical companies that utilize CDMOs or CROs to develop peptide syntheses and an increase in R&D spending on new technologies to discover and produce new peptides will result in additional investment into the expanding markets for peptide products and strengthen the growth of the UK peptide synthesis market.

The United Kingdom peptide synthesis market faces challenges such as intense competition from established global peptide manufacturing hubs and emerging low-cost producers, creating pricing pressures from pharmaceutical and biotechnology customers.

The future outlook for the United Kingdom peptide synthesis market appears to be very bright and promising, supported by the advancements in automated solid phase synthesis, continuous flow technologies, green chemistry approaches, and the digital laboratory platforms. The convergence of automation, real-time reaction monitoring, advanced analytical tools, AI-assisted peptide design, and the data-driven process optimization is improving the product purity, reducing development timelines, and strengthening the regulatory compliance. These innovations are accelerating the development of therapeutic peptides, peptide-based vaccines, and precision medicines, while expanding applications in biotechnology and academic research.

Market Segmentation

The United Kingdom peptide synthesis market share is classified into technology, application and end use

By Technology

The United Kingdom peptide synthesis market is divided by technology into liquid phase peptide synthesis (LPPS), solid phase peptide synthesis (SPPS), and hybrid technology. Among these, the solid phase peptide synthesis (SPPS) segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. It is because of the speed, efficiency, high automation, and suitability for producing complex, longer peptides.

By Application

The United Kingdom peptide synthesis market is divided by application into therapeutics, cancer, metabolic, cardiovascular disorder, infectious diseases, CNS, gastrointestinal disorders (GIT), pain, respiratory, dermatology, renal disorders, and others. Among these, the DNA sequencing segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. It is because of the growing incidence of diabetes and obesity in the UK has accelerated the demand for peptide-based drugs like GLP-1 agonists.

By End Use

The United Kingdom peptide synthesis market is divided by end use into pharmaceutical & biotechnology companies, CDMOS & CROS, and academic & research institutes. Among these, the pharmaceutical & biotechnology companies segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. It is because of the Intense focus on developing peptide-based therapeutics for chronic diseases like cancer, diabetes, and cardiovascular conditions.

Competitive Analysis

The report offers the appropriate analysis of the key organisations/companies involved within the United Kingdom peptide synthesis market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

Top Key Companies in United Kingdom Peptide Synthesis Market

• Thermo Fisher Scientific
• Bachem Holding AG
• PolyPeptide Group
• Merck KGaA
• GenScript Biotech
• Lonza Group
• Biotage
• Kaneka Corporation (AnaSpec)
• Creative Diagnostics
• Others

Recent Development in United Kingdom Peptide Synthesis Market

In June 2024, Vapourtec launched the Peptide-ExplorerLT, a compact and versatile peptide synthesizer designed for efficient linear peptide production, strengthening innovation and advanced instrumentation capabilities within the expanding UK peptide synthesis market.

In May 2024, Activotec Ltd launched the Activo-Darwin Semi-Automated Peptide Synthesizer, designed to deliver high-quality peptide synthesis with improved flexibility and efficiency, strengthening innovation and instrumentation capabilities within the growing UK peptide synthesis market.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom peptide synthesis market based on the below-mentioned segments:

United Kingdom Peptide Synthesis Market, By Technology

• Liquid Phase Peptide Synthesis (LPPS)
• Solid Phase Peptide Synthesis (SPPS)
• Hybrid Technology

United Kingdom Peptide Synthesis Market, By Application

• Therapeutics
• Cancer
• Metabolic
• Cardiovascular Disorder
• Infectious Diseases
• CNS
• Gastrointestinal Disorders (GIT)
• Pain
• Respiratory
• Dermatology
• Renal Disorders
• Others

United Kingdom Peptide Synthesis Market, By End Use

• Pharmaceutical & Biotechnology Companies
• CDMOs & CROs
• Academic & Research Institutes